Eyes and vision, Guidance

Applied filters

Care Setting (1)
- Neonates (1)
- Paediatrics (1)
Guidance (55)
- Administering (1)
- Excipients (1)
- In-use stability (1)
- Medication Safety (1)
- Safety in Breastfeeding (47)
- Temperature management (14)
  - Stability outside the fridge (14)
Medicine (53)
- Acetazolamide (2)
- Acetylcysteine (1)
- Aciclovir (1)
- Adalimumab (1)
- Aflibercept (2)
- Atropine (2)
- Azelastine (1)
- Azithromycin (1)
- Bevacizumab (1)
- Bimatoprost (2)
- Cefuroxime (2)
- Chloramphenicol (3)
- Ciclosporin (1)
- Ciprofloxacin (1)
- Cyclopentolate (2)
- Diclofenac sodium (2)
- Eculizumab (1)
- Flurbiprofen (2)
- Fusidic acid (1)
- Ganciclovir (1)
- Gentamicin (1)
- Latanoprost (2)
- Latanoprost + Timolol (1)
- Levobunolol (2)
- Levofloxacin (1)
- Lidocaine (1)
- Liquid paraffin (1)
- Macrogol 3350 (1)
- Mercaptamine (1)
- Moxifloxacin (1)
- Nedocromil (1)
- Ocriplasmin (1)
- Ofloxacin (1)
- Phenylephrine (2)
- Pilocarpine (2)
- Povidone (2)
- Proxymetacaine (2)
- Ranibizumab (2)
- Sirolimus (1)
- Sodium chloride (1)
- Sodium cromoglicate (1)
- Sodium hyaluronate (1)
- Tafluprost (2)
- Tetracaine (2)
- Timolol (2)
- Tobramycin (1)
- Yellow soft paraffin (1)
Medicines planning (21)
- Biosimilars (1)
- New Medicines (13)
  - CCG commissioned new medicines (11)
  - NHS England commissioned new medicines (4)
  - Pre-registration new medicines (UK/EU) (4)
- Patent expiries (17)
Specialty (55)
- Allergy and immunology (2)
- Anaesthesia and pain (5)
- Cancers (4)
- Cardiovascular system disorders (3)
- Ear, nose and throat disorders (6)
- Eyes and vision (55)
- Gastrointestinal disorders (3)
- Haematological disorders (3)
- Infection and infectious diseases (11)
- Musculo-skeletal disorders (5)
- Nutritional and metabolic disorders (2)
- Obstetrics and gynaecology (1)
- Respiratory disorders (4)
- Skin disorders (7)

Using chloramphenicol during breastfeeding

16 June 2022Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.

Using chloramphenicol eye products in children under 2 years

29 April 2021Chloramphenicol eye drops that contain boron or borates (borax or boric acid) can be safely used in children under 2 years where indicated.

SPS Advice Note: Interim position statement 3; BD Field Safety Notice (FSN) and intraocular injections (BD and other syringes)

18 February 2021Advice following the issue of the BD Urgent Field Safety Notice MPS-18-1209 regarding the use of BD and BBraun (Medline) syringes for intraocular injections.

Safety in Lactation: Mydriatics and cycloplegics

4 November 2020Mydriatics and cycloplegics have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant, especially when used as a single dose…

Safety in Lactation: Local anaesthetic eye preparations

15 October 2020Local anaesthetics for ophthalmic use have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. Systemic absorption from eye drops…

Safety in Lactation: Ocular peri-operative preparations

23 September 2020Drugs in this group have varying uses immediately before, during or following eye surgery. Their use is, therefore, usually on a relatively short-term basis. In…

Safety in Lactation: Subfoveal choroidal neovascularisation

21 September 2020VEGF inhibitors are used for age-related macular degeneration, administered by intravitreal injection. They are also large molecules with a high molecular weight. These factors will…

Safety in Lactation: Treatment of glaucoma

18 September 2020With the exception of acetazolamide (oral/IV) antiglaucoma drugs are administered as eyedrops which have limited systemic absorption in the mother, and pose negligible risk to…

Guidance on In Use Shelf Life for Eye Drops and Ointments

16 December 2019This document takes a risk based approach to assigning the in- use shelf life for eye drops used in UK hospitals based on the risks…

SPS - Specialist Pharmacy Service

NHS